Use of a high resolution melting (HRM) assay to compare Gag, Pol, and Env diversity in adults with different stages of HIV infection

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Cousins, Matthew M ^a   Laeyendecker, Oliver ^a,b   Beauchamp, Geetha ^c   Brookmeyer, Ronald ^d   Towler, William I ^a   Hudelson, Sarah E ^a   Khaki, Leila ^a   Koblin, Beryl ^e   Chesney, Margaret ^f   Moore, Richard D ^a   Kelen, Gabor D ^a   Coates, Thomas ^d   Celum, Connie ^g   Buchbinder, Susan P ^f,h   Seage III, George R ⁱ   Quinn, Thomas C ^a,b   Donnell, Deborah ^c   Eshleman, Susan H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK BLOOD CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAG PROTEIN; GAG1 PROTEIN; GAG2 PROTEIN; GAG3 PROTEIN; POL PROTEIN; RNA ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN1; VIRUS ENVELOPE PROTEIN2; VIRUS ENVELOPE PROTEIN3; VIRUS RNA; PRIMER DNA;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEROCONVERSION; ADULT; COMPARATIVE STUDY; ENVELOPE GENE; GENETICS; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURAL GENE;

ADULT; BASE SEQUENCE; DNA PRIMERS; GENES, ENV; GENES, GAG; GENES, POL; GENETIC VARIATION; HIV INFECTIONS; HUMANS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80355146254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027211     Document Type: Article

References (39)

1. Brookmeyer R, (2010) Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev 32: 26-37.
2. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS, (2004) Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 42: 2623-2628.
3. Murphy G, Parry JV, (2008) Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 13.
4. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, et al. (2009) Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 9: 747-759.
5. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, et al. (2010) Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 24: 2763-2771.
6. Vrancken B, Lequime S, Theys K, Lemey P, (2010) Covering all bases in HIV research: unveiling a hidden world of viral evolution. AIDS Rev 12: 89-102.
7. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, et al. (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73: 10489-10502.
8. Kearney M, Palmer S, Maldarelli F, Shao W, Polis MA, et al. (2008) Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase. AIDS 22: 497-501.
9. Keele BF, (2010) Identifying and characterizing recently transmitted viruses. Curr Opin HIV AIDS 5: 327-334.
10. Tebit DM, Nankya I, Arts EJ, Gao Y, (2007) HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle? AIDS Rev 9: 75-87.
11. Richman DD, Little SJ, Smith DM, Wrin T, Petropoulos C, et al. (2004) HIV evolution and escape. Trans Am Clin Climatol Assoc 115: 289-303.
12. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7557.
13. Li H, Bar KJ, Wang S, Decker JM, Chen Y, et al. (2010) High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog 6: e1000890.
14. Delwart EL, Pan H, Sheppard HW, Wolpert D, Neumann AU, et al. (1997) Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol 71: 7498-7508.
15. Learn GH, Muthui D, Brodie SJ, Zhu T, Diem K, et al. (2002) Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol 76: 11953-11959.
16. Piantadosi A, Chohan B, Panteleeff D, Baeten JM, Mandaliya K, et al. (2009) HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response. AIDS 23: 579-587.
17. Liu S, Xing H, He X, Xin R, Zhang Y, et al. (2008) Dynamic analysis of genetic diversity of gag and env regions of HIV-1 CRF07_BC recombinant in intravenous drug users in Xinjiang Uvghur Autonomous Region, China. Arch Virol 153: 1233-1240.
18. Frahm N, Brander C, (2007) HIV viral diversity and escape from cellular immunity. Curr Infect Dis Rep 9: 161-166.
19. Kouyos RD, von Wyl V, Yerly S, Boni J, Rieder P, et al. (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 52: 532-539.
20. Wilson E, Shao W, Brooks J, Dewar R, Kearney M, et al. (2011) New bioinformatic algorithm to identify recent HIV-1 infection. 18th Conf on Retroviruses and Opportunistic Infections, Boston, MA, Abstract # 1057.
21. Towler WI, James MM, Ray SC, Wang L, Donnell D, et al. (2010) Analysis of HIV diversity using a high-resolution melting assay. AIDS Res Hum Retroviruses 26: 913-918.
22. Montgomery JL, Sanford LN, Wittwer CT, (2010) High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn 10: 219-240.
23. James MM, Wang L, Musoke P, Donnell D, Fogel J, et al. (2011) Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS ONE 6: e18642.
24. Koblin B, Chesney M, Coates T, (2004) Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet 364: 41-50.
25. Celum C L, Buchbinder S P, Donnell D, Douglas J M, Mayer K, et al. (2001) Early human immunodeficiency virus (HIV) infection in the HIV network for prevention trials vaccine preparedness cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J of Infect Dis 183: 23-35.
26. Moore RD, (1998) Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retrovirol 17 (Suppl 1): S38-41.
27. Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, et al. (2008) The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department. J Acquir Immune Defic Syndr 48: 211-215.
28. Eshleman SH, Khaki L, Laeyendecker O, Piwowar-Manning E, Johnson-Lewis L, et al. (2009) Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr 52: 121-124.
29. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879.
30. Swanson P, Devare SG, Hackett J Jr, (2003) Molecular characterization of 39 HIV isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 19: 625-629.
31. Badreddine S, Smith K, van Zyl H, Bodelle P, Yamaguchi J, et al. (2007) Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found. AIDS Res Hum Retroviruses 23: 667-674.
32. Reed GH, Wittwer CT, (2004) Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 50: 1748-1754.
33. Dorn J, Masciotra S, Yang C, Downing R, Biryahwaho B, et al. (2000) Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection. J Clin Microbiol 38: 773-780.
34. Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, et al. (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol 84: 6241-6247.
35. Long EM, Martin HL Jr, Kreiss JK, Rainwater SM, Lavreys L, et al. (2000) Gender differences in HIV-1 diversity at time of infection. Nat Med 6: 71-75.
36. Machado D, Delwart E, Diaz R, de Oliveira C, Alves K, et al. (2002) Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS 16: 113-119.
37. Laeyendecker O, Oliver A, Astemborski J, Owen M, Kirk G, et al. (2010) Improved precision of cross-sectional HIV incidence testing assing a multi-assay algorithm that Includes BED and an avidity assay with modified assay cut-offs. 17th Conf on Retroviruses and Opportunistic Infections, San Francisco, CA, Abstract # 935.
38. Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, et al. (2010) Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward. J HIV AIDS Surveill Epidemiol 2: 1-14.
39. Kuiken C, Foley B, Leitner T, Apetrei C, Hahn B, et al.eds. (2010) HIV Sequence Compendium 2010. Los Alamos, NM Los Alamos National Laboratory, Theoretical Biology and Biophysics.